Palomino Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-3.16	-0.02	-0
Stock-Based Compensation	1.44	-	-
Other Operating Activities	0.46	0.01	-0.01
Change in Accounts Payable	0.28	0	0
Change in Other Net Operating Assets	-0.31	-0	-
Operating Cash Flow	-1.28	-0	-0.01
Long-Term Debt Issued	1.7	-	-
Total Debt Issued	1.7	-	0.17
Short-Term Debt Repaid	-0	-	-
Long-Term Debt Repaid	-0.35	-	-
Total Debt Repaid	-0.35	-	-
Net Debt Issued (Repaid)	1.34	-	0.17
Issuance of Common Stock	9.76	-	0
Other Financing Activities	-1.83	-	-
Financing Cash Flow	9.27	-	0.17
Net Cash Flow	7.99	-0	0.15
Levered Free Cash Flow	-0.22	-0.01	-
Unlevered Free Cash Flow	-0.22	-0.01	-
Change in Working Capital	-0.02	-0	0